To: AriKirA who wrote (3392 ) 3/9/1999 2:11:00 PM From: LOR Respond to of 8117
AriK, that "Market Efficiency" post was great Quoting in part, ***************************** ""To these four kinds of information correspond three forms of market efficiencies. The weak form of efficiency says that all public information about the old prices, volumes and so on are included in the price of a security. The middle form of efficiency says that all public information (thus, including non published information that can be obtained by research) is included in the securities price. The strong form of efficiency includes all information (public or not)in the securities price. While the strong form of the Efficient Market Hypothesis is thought to be unrealistic, the weak and the middle form are widely accepted for developed western capital markets. "" ****************************** Based on the above, I believe PYNG is indeed priced according to the "middle form of efficiency". The research todate can be summarized as follows: 1) PYNG [ and others ] have workable "adult intraosseous infusion device" products, 2) the market for said devices is in the process of been developed but at this time can best be described by the word "potential", 3) no credible independent organisation is officially indicating that there is a "product of choice" 4) none of the four suppliers of adult intraosseous devices has announced the receipt of major orders for their device for use on ""ADULTS"", 5) todate, the medical community "at large" has not established the roll of these devices in "emergency" medicine, *************************************** Only new information can affect the price. But new information appears randomly--so its appearance can't be predicted **************************************** Actually, ...it can be "predicted, forecasted and/or imagined in advance" and of course this has been a major concern to PYNG investors who have seen that PYNG's forecasts have had about the same accuracy as "long range" weather forecasts. Still, we all know that the sun will someday shine on PYNG...or at least I believe it...The real question is whether or not it will be in this or the next millinium. ********************************************** In my opinion the current stock price has nothing to do with potential and everything with lack of interest. ********************************************** Actually, I suspect that there is considerable "interest" in PYNG but that investment managers are asking "WHERE'S THE BEEF" which of course is a significant 'MASS PRODUCTION" order. GWB regarding your comment "If however FAST1 was the only choice for the military, investors would naturally feel a little more secure,and this would reflect in the share price." I believe the GOOD NEWS is: 1) that the market is more then big enough for more then one manufacturer of intraosseous products AND 2) that the military have accepted the FAST-1 and probably do prefer it "informally" for the vast majority of military environments, 3) that PYNG has done as good or better in establishing itself for "mass production" sales of "ADULT" devices then it's competitors and that PYNG's performance in this area far exceeds its performance in "shareholder information" releases, Grant MacMillan's comment "" So, until Pyng releases news about orders, including how much, my guess is that we're stuck here. Certainly not what I expected a year ago. "" is I.M.H.O 100% on the mark. It is time for the "kettle" to get off the "pot" and land that first M.P. order. I have no doubts that once that order has been logged that shareholders will be immediately advised as it would seem almost criminal not to do so in light of PYNG's history. ...... And of course that announcement may be only seconds, minutes, hours, days or months away !!! I also believe that once the "BEEF" has been announced that there will be a minor stampead on the part of investment managers to get in before the price goes through the roof as the announcement that a major order has been placed will tell the investment community that "adult intraosseous infusion devices" have finally been accepted as viable "products" as opposed to mere research toys. Good luck to all, LOR